Back to Journals » Breast Cancer: Targets and Therapy » Volume 4

Potential of afatinib in the treatment of patients with HER2-positive breast cancer

Total article views   HTML views PDF downloads Totals
14,157 Dovepress* 12,462+ 3,126 15,588
PubMed Central* 1,695 1,438 3,133
Totals 14,157 4,564 18,721
*Since 27 August 2012
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 0 0 0 3 5

View citations on PubMed Central and Google Scholar